These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042 [TBL] [Abstract][Full Text] [Related]
5. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments. Ancona-Lezama D; Dalvin LA; Lucio-Alvarez JA; Jabbour P; Shields CL Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728 [TBL] [Abstract][Full Text] [Related]
6. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras. Dalvin LA; Ancona-Lezama D; Lucio-Alvarez JA; Masoomian B; Jabbour P; Shields CL Ophthalmology; 2018 Nov; 125(11):1803-1811. PubMed ID: 29921454 [TBL] [Abstract][Full Text] [Related]
7. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423 [TBL] [Abstract][Full Text] [Related]
8. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941 [TBL] [Abstract][Full Text] [Related]
9. Intra-arterial chemotherapy for retinoblastoma: First Indian report. Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473 [TBL] [Abstract][Full Text] [Related]
10. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434 [TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach. Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742 [TBL] [Abstract][Full Text] [Related]
14. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Eagle RC; Shields CL; Bianciotto C; Jabbour P; Shields JA Arch Ophthalmol; 2011 Nov; 129(11):1416-21. PubMed ID: 21746972 [TBL] [Abstract][Full Text] [Related]
15. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944 [TBL] [Abstract][Full Text] [Related]
16. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma. Rusakevich AM; Nahhas MI; Zhou B; Dannenbaum MJ; Bretana ME; Schefler AC Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1321-1328. PubMed ID: 38032379 [TBL] [Abstract][Full Text] [Related]
17. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision. Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611 [TBL] [Abstract][Full Text] [Related]
18. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey. Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798 [TBL] [Abstract][Full Text] [Related]
19. Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach. Daniels AB; Froehler MT; Nunnally AH; Pierce JM; Bozic I; Stone CA; Santapuram PR; Tao YK; Boyd KL; Himmel LE; Chen SC; Du L; Friedman DL; Richmond A Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):954-964. PubMed ID: 30882851 [TBL] [Abstract][Full Text] [Related]
20. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment. Shields CL; Kaliki S; Shah SU; Bianciotto CG; Jabbour P; Shields JA Retina; 2012 Apr; 32(4):799-804. PubMed ID: 22105496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]